Skip to main content
Premium Trial:

Request an Annual Quote

Richard Begley, Matt Watson, Shiela Robertson

PerkinElmer said this week that Richard Begley has joined the company as vice president and general manager of its Analytical Sciences business. Begley had been president and CEO of Ensemble Discovery. He had the same title at 454 Life Sciences before that and held various positions at Hewlett Packard and its spinoff, Agilent Technologies.
Begley received his PhD in applied physics from StanfordUniversity.

CombiMatrix Molecular Diagnostics this week said it has appointed Mansoor Mohammed CEO of the company, replacing Matt Watson who left to pursue other opportunities. Mansoor was already president of the company as well as its COO.
Watson will remain as a consultant with CombiMatrix for three months, the company said.

Agilent said this week Shiela Robertson will be replacing John Eaton as vice president of corporate development. Eaton will retire on April 30, after 23 years at Agilent and Hewlett Packard.
Robertson will be replaced as operational CFO of the Electronic Measurement Group by Robert Cantrell, who is currently group controller of Agilent’s Global Infrastructure Organization.

Robertson started out as a financial analyst at Hewlett Packard in 1980. She received her bachelor’s degree and MBA from Santa Clara University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.